Zevra Therapeutics announced the appointments of Rahsaan W. Thompson as Chief Legal Officer, Secretary and Compliance Officer, and Alison Peters as Chief People Officer. Both Mr. Thompson and Ms. Peters bring deep expertise in building high-performing teams which will be essential to deliver success through the Company’s next phase of growth. “We are thrilled to welcome both Rahsaan and Alison to the Zevra team as we continue the expansion and progress of our rare disease portfolio,” said Neil F. McFarlane, President and Chief Executive Officer of Zevra. “Their roles will be instrumental to driving our evolution into a leading rare disease therapeutics company.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZVRA:
- Zevra Therapeutics Expands Executive Leadership Team
- Zevra transitions to Orsini as specialty pharmacy provider for OLPRUVA
- Zevra Therapeutics selects Orsini as specialty pharmacy partner for Olpruva
- Zevra Therapeutics Transitions to Orsini as the Specialty Pharmacy Provider for OLPRUVA® (sodium phenylbutyrate), a Treatment for Certain Urea Cycle Disorders
- Zevra Therapeutics files $350M mixed securities shelf